Literature DB >> 922224

The speech spectrum--some aspects of its significance for hearing aid selection and evaluation.

D Byrne.   

Abstract

A spectral analysis of Australian speech is reported for 30 speakers, 15 males and 15 females. When expressed in one-third octave band levels, or critical band levels, the spectrum is essentially flat from 1kHz to 8KHz and shows approximately 15dB greater energy at 0.5kHz and lower frequencies. Although the results of this study agree substantially with other published data, the use of the average spectrum obtained, rather than the idealised speech spectrum, would be significant for aid selection and evaluation purposes. The common practice, in hearing aid literature, of showing the speech spectrum expressed in spectrum levels, rather than one-third octave band levels, may lead to a different, and possibly misleading, conceptualisation of the relative energy of high and low frequency components. Considering that speech spectra differ greatly from one individual to another, it would seem desirable that speech with a known, preferably average, spectrum be used in hearing aid evaluation procedures which involve setting the volume control of a hearing aid to deliver speech at a comfortable listening level.

Mesh:

Year:  1977        PMID: 922224     DOI: 10.3109/03005367709078831

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  3 in total

Review 1.  New perspectives on assessing amplification effects.

Authors:  Pamela E Souza; Kelly L Tremblay
Journal:  Trends Amplif       Date:  2006-09

2.  Analog-to-digital conversion to accommodate the dynamics of live music in hearing instruments.

Authors:  Neil S Hockley; Frauke Bahlmann; Bernadette Fulton
Journal:  Trends Amplif       Date:  2012-09

3.  Spectro-temporal characteristics of speech at high frequencies, and the potential for restoration of audibility to people with mild-to-moderate hearing loss.

Authors:  Brian C J Moore; Michael A Stone; Christian Füllgrabe; Brian R Glasberg; Sunil Puria
Journal:  Ear Hear       Date:  2008-12       Impact factor: 3.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.